MIR5700

Across TCGA pan-cancer cohorts, MIR5700 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated MIR5700 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher MIR5700 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR5700 expression acts as an unfavorable survival marker, although some lineages such as ESCA and COAD show a favorable association.

LUAD, BRCA, and LIHC are the cancer types where MIR5700 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	II,III,IV	0.127	0.750	<.001	75	view →
BRCA	OS	Tertile	III,IV	0.638	0.910	.008	36	view →
LIHC	OS	Tertile	All	0.089	0.783	<.001	36	view →
ESCA	OS	Median	III,IV	0.587	0.305	.002	18	view →
LUSC	OS	Tertile	All	0.234	0.524	.020	18	view →
UCEC	OS	Tertile	IV	0.308	0.748	.009	18	view →
COAD	DFS	Tertile	All	1.000	0.519	.024	15	view →
KIRP	DFS	Tertile	All	0.366	0.805	.021	12	view →
PRAD	DFS	Tertile	All	0.975	0.758	.029	12	view →
STAD	DFS	Tertile	All	0.607	0.770	.029	10	view →
MESO	DFS	Tertile	All	1.000	0.179	.041	9	view →
THCA	DFS	Tertile	All	1.000	0.933	.017	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

MIR5700–LUAD (OS)

Open the LUAD breakdown →